Ditai Bio Inks Multi-Target Molecular Glue Platform Deal with Roche to Accelerate Novel Molecular Glue Degrader R&D | Unity Ventures Portfolio
Advancing innovative therapies to meet the urgent needs of patients with cancer and immune diseases
Advancing innovative therapies to meet the urgent needs of patients with cancer and immune diseases
The First RISC-V Stock
How should a founder work with their team? What are the things I haven't done well myself? And how can I do better?
We compiled our test results for Vidu Q4 Preview ahead of the official release.
Making Smart Glasses a Product Users Actually Want to Wear Long-Term
Another agent replies to you with a wall of text; this one just hands you an app.
Technology is reconnecting industries. This list documents the venture capital forces taking part, the investors behind them, and the depth each has reached.
Enable robots to learn on the fly in new environments through a handful of demonstrations and self-directed trial and error — no retraining required.
Advance the development of native embodied foundation models with propulsion capabilities.